FDA Approval of Abortion Drug Sparks Controversy

The recent approval of a widely used abortion drug by the FDA has drawn criticism from social conservatives, who view it as a betrayal by a government they see as their ally in life advocacy.

Evita Solutions, a pharmaceutical company, announced last week that the FDA approved a new version of mifepristone. This drug can be used anywhere from the first day to the 70th day following a woman’s last menstrual period, according to Evita.

Mifepristone is part of a two-step regimen for abortion. It works by blocking progesterone, which breaks down the uterine lining and leads to the termination of the pregnancy. The second medication, misoprostol, is taken afterward to induce contractions to expel the fetus.

Senator Josh Hawley (R-Mo.) expressed shock at the FDA’s decision, labeling chemical abortion drugs as “dangerous” and potentially fatal for mothers. He remarked, “The FDA had committed to thorough safety reviews, but they simply approved the new versions without adequate scrutiny. I’ve lost trust in their leadership.”

In a tweet, Hawley stated, “This is shocking. The FDA has just approved another chemical abortion drug, even as evidence shows they can be dangerous and fatal for mothers. And, of course, they are 100% fatal for children.”

Abortions in the U.S. often utilize drugs that were first authorized during the Clinton administration in 2000, although the restrictions have been significantly relaxed under the Obama and Biden administrations.

Lila Rose, the president of Live Action, criticized the FDA’s approval of the new generic mifepristone, calling it “unacceptable.” She questioned the FDA’s decision, pointing out that they had promised a serious safety review and yet went ahead with the approval.

She also tweeted, “The FDA has approved another generic version of mifepristone. This drug will starve babies and harm mothers! Why approve another generic now after claiming to conduct a safety investigation?”

Gary Hollingsworth, the interim president of the Southern Baptist Convention’s Ethics and Religious Freedom Committee, called for the FDA to revisit its decision. He stated that life is a “sacred gift” and should not be treated as something that is merely regulated or discarded. In response, the ERLC is sending a letter to Health and Human Services and the FDA urging action to remove this “dangerous” drug from the market.

Kennedy replied to these concerns by emphasizing that the FDA is legally obligated to approve drugs like mifepristone. He noted, “The FDA only approved the second generic tablets because federal law necessitates approval if they demonstrate the same safety as the branded drug.” He also pointed out that the Biden administration had lifted some dispensing regulations without investigating the safety risks.

In a recent study conducted by the Center for Ethics and Public Policy, researchers found that abortion drugs are significantly more dangerous than previously reported by manufacturers. Specifically, they found that 10.93% of women who used mifepristone experienced serious complications, including sepsis and significant bleeding, within 45 days.